Literature DB >> 10030812

Primary mucosal and glans penis melanomas: the Sydney Melanoma Unit experience.

K B Larsson1, H M Shaw, J F Thompson, R C Harman, W H McCarthy.   

Abstract

BACKGROUND: Melanomas that arise on mucosal surfaces and the glans penis are rare.
METHODS: A retrospective study of the Sydney Melanoma Unit experience with 69 patients treated since 1956 for these types of melanomas was undertaken to determine primary lesion site, sex, age at diagnosis, symptoms, clinical stage at first presentation. histopathology, treatment and outcome.
RESULTS: Primary lesion sites were: nasal cavity (n = 9), oral cavity (n = 16), vulva/vagina (n = 25), anus/rectum (n = 13) and glans penis (n = 6). At diagnosis, 55 patients had local disease only, eight had regional lymph node metastases and six had widespread disease. Local recurrence as the first sign of relapse developed in 15 of the 55 stage I patients (three-stage system). Prognosis for the entire group was poor, only 10% being disease free 3 years after diagnosis and overall 3- and 5-year actuarial survival being 40% and 23%. respectively. The only statistically significant factor influencing survival was stage of disease at diagnosis (P = 0.002).
CONCLUSIONS: Possible reasons for poor survival include: (i) non-specific symptoms resulting in late presentation; (ii) locally advanced disease not being recognized by a clinician as a rare form of melanoma, resulting in a delay in treatment; (iii) anatomical constraints precluding surgery with generous margins and consequently resulting in a high incidence of local recurrence. Also, rich vascularity and multiple lymphatic drainage pathways may mean a predisposition to early dissemination. Prompt diagnosis and referral to a specialist unit for treatment and follow up are essential. Adequate surgery remains the cornerstone of treatment for these types of melanoma until more effective systemic therapies become available.

Entities:  

Mesh:

Year:  1999        PMID: 10030812     DOI: 10.1046/j.1440-1622.1999.01497.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  4 in total

1.  Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology.

Authors:  Ozlem Ercelep; Turkan Ozturk Topcu; Ibrahim Vedat Bayoglu; Ahmet Siyar Ekinci; Sinan Koca; Halil Kavgaci; Melike Ozcelik; Ahmet Alacacioglu; Sernaz Uzunoglu; Oktay Bozkurt; Arife Ulas; Asude Aksoy; Burcu Yapar Taskoylu; Ozge Gumussay; Sebnem Yaman; Mukremin Uysal; Dincer Aydin; Mahmut Gumus
Journal:  Tumour Biol       Date:  2016-05-12

2.  Oral Malignant Melanoma in a Patient With Neurofibromatosis Type 1: An Extremely Rare Association.

Authors:  Soufiane Berhili; Mohammed Rezzoug; Ahmed Ben Sghier; Mohammed Moukhlissi; Loubna Mezouar
Journal:  Cureus       Date:  2022-05-25

Review 3.  A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker.

Authors:  Viola A Heinzelmann-Schwarz; Sheri Nixdorf; Mehrnaz Valadan; Monica Diczbalis; Jake Olivier; Geoff Otton; André Fedier; Neville F Hacker; James P Scurry
Journal:  Int J Mol Med       Date:  2014-02-14       Impact factor: 4.101

4.  Malignant melanoma in Chile: different site distribution between private and state patients.

Authors:  Viviana B Zemelman; Carlos Y Valenzuela; Ivo Sazunic; Irene Araya
Journal:  Biol Res       Date:  2014       Impact factor: 5.612

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.